NCT05696548 2026-04-09Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION)National Cancer Center Hospital EastPhase 2 Active not recruiting51 enrolled
NCT04171622 2026-02-17Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid CancerM.D. Anderson Cancer CenterPhase 2 Active not recruiting25 enrolled